GlassScriptPhysician profile
Jeffrey J Betman
NPI 1891793907
$1,286.24
in general payments reported to CMS, 2019-2025
24 companies · $294 in 2025
The $294 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.26 · 2020: $110 · 2021: $194 · 2022: $145 · 2023: $178 · 2024: $299 · 2025: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $771.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $771.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $213.22 | 2024-2025 | Ortholoc 3di, Allomatrix, Viaflow |
| Organogenesis INC. | $189.03 | 2020-2023 | Puraply |
| Smith+Nephew, INC. | $145.20 | 2019-2025 | Grafix Pl |
| Zimmer Biomet Holdings, INC. | $102.35 | 2020-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $94.61 | 2022 | |
| Paratek Pharmaceuticals, INC. | $83.17 | 2022-2025 | Nuzyra |
| Orthofix Medical, INC. | $51.42 | 2021-2023 | Physio-Stim |
| Amgen INC. | $51.38 | 2024-2025 | Krystexxa |
| Kerecis Limited | $49.32 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Paragon 28, INC. | $38.01 | 2025 | Hammertube Sterile Implant Kits |
| Abbott Laboratories | $28.69 | 2024 | Proclaim |
| Vertex Pharmaceuticals Incorporated | $24.93 | 2025 | |
| Depuy Synthes Sales INC. | $24.42 | 2022 | |
| Ermi LLC | $22.46 | 2021 | |
| Lightbody Medical Technologies INC | $22.14 | 2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $21.33 | 2023 | |
| Mimedx Group, INC. | $20.62 | 2025 | |
| Osiris Therapeutics INC. | $17.91 | 2019 | |
| Ibsa Pharma INC. | $16.67 | 2023 | Tirosint, Licart |
| Next Science LLC | $15.75 | 2023 | Xperience, Blastx, Surgx |
| Kowa Pharmaceuticals America, INC. | $15.63 | 2023 | Seglentis |
| Treace Medical Concepts, INC. | $14.99 | 2025 | |
| Cardiovascular Systems INC. | $12.18 | 2019 | |
| Merck Sharp & Dohme LLC | $10.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Betman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.